A number of approved treatments , including copyright and Semaglutide, belong to the incretin mimetic class . Mainly, these drugs work by mimicking endogenous substances that regulate glucose levels and https://poppykprx898643.blogacep.com/46742071/copyright-and-glp-1-receptor-agonists-getting-to-know-the-medications